MROPF
vs
S&P 500
MROPF
S&P 500
Over the past 12 months, MROPF has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +19% growth.
Stocks Performance
MROPF vs S&P 500
Performance Gap
MROPF vs S&P 500
Performance By Year
MROPF vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Microport Cardioflow Medtech Corp
Glance View
MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-02-04. The firm is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The firm's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The firm mainly conducts business within the domestic market.